Bora Pharmaceuticals Co., Ltd. (TPE:6472)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Sales Operations Department	17.13B	9.25B	5.76B	532.39M	500.32M
Sales Operations Department Growth	85.16%	60.59%	982.02%	6.41%	19.55%
CDMO Operations Department	6.92B	5.44B	4.84B	4.42B	1.31B
CDMO Operations Department Growth	27.28%	12.44%	9.43%	236.74%	13.37%
Other Operations Department	802.33M	273.38M	202.85M	85.09M	40.19M
Other Operations Department Growth	193.49%	34.77%	138.41%	111.69%	2142.91%
Adjustments and Eliminations	-5.61B	-761.19M	-304.00M	-135.84M	-53.01M
Total	19.25B	14.20B	10.49B	4.90B	1.80B
Total Growth	35.53%	35.31%	114.18%	172.28%	17.68%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Europe	2.13B	2.08B	3.13B	3.39B	214.75M
Europe Growth	2.28%	-33.51%	-7.78%	1480.09%	-
United States	15.44B	10.96B	6.51B	861.59M	968.95M
United States Growth	40.95%	68.17%	656.10%	-11.08%	-0.61%
Taiwan	1.43B	1.05B	850.69M	645.02M	615.87M
Taiwan Growth	35.73%	23.81%	31.88%	4.73%	11.11%
Other	246.83M	110.93M	-	-	-
Other Growth	122.51%	-	-	-	-
Total	19.25B	14.20B	10.49B	4.90B	1.80B
Total Growth	35.53%	35.31%	114.18%	172.28%	17.68%

Source: S&P Global Market Intelligence.